 | Up a level |
Ruhstaller, Thomas; Pless, Miklos; Dietrich, Daniel; Kranzbuehler, Helmut; von Moos, Roger; Moosmann, Peter; Montemurro, Michael; Schneider, Paul M; Rauch, Daniel; Gautschi, Oliver; Mingrone, Walter; Widmer, Lucas; Inauen, Roman; Brauchli, Peter; Hess, Viviane (2011). Cetuximab in combination with chemoradiotherapy before surgery in patients with resectable, locally advanced esophageal carcinoma: a prospective, multicenter phase IB/II Trial (SAKK 75/06). Journal of clinical oncology, 29(6), pp. 626-31. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.31.9715
Klaeser, Bernd; Nitzsche, Egbert; Schuller, Jan C; Köberle, Dieter; Widmer, Lucas; Balmer-Majno, Sabine; Hany, Thomas; Cescato-Wenger, Corinne; Brauchli, Peter; Zünd, Michael; Pestalozzi, Bernhard C; Caspar, Clemens; Albrecht, Susanne; von Moos, Roger; Ruhstaller, Thomas (2009). Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer: results of a prospective multi-center trial (SAKK 75/02). Onkologie, 32(12), pp. 724-30. Basel: Karger 10.1159/000251842
